New hope for keeping aggressive bile duct cancer at bay
NCT ID NCT07269158
Summary
This study aims to find the best way to keep advanced bile duct cancer under control after initial treatment. It will test different drug combinations in 160 patients whose cancer responded to first-line therapy. The goal is to see which approach keeps the cancer from growing longer while maintaining quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine, Korea
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.